AZN EBITDA
AstraZeneca PLC Ordinary Shares · EBITDA
AZN EBITDA
Latest reported$20.69Bperiod ending
AZN EBITDA ($1.37B → $20.69B)
Annual EBITDA
High-resolution chart · PNG
AZN ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 19,829,000,000 | |
| 15,438,000,000 | |
| 13,422,000,000 | |
| 9,085,000,000 | |
| 5,113,000,000 | |
| 8,084,000,000 | |
| 6,712,000,000 | |
| 7,112,000,000 | |
| 6,623,000,000 | |
| 7,276,000,000 | |
| 6,960,000,000 | |
| 5,491,000,000 | |
| 8,342,000,000 | |
| 10,683,000,000 | |
| 15,387,000,000 | |
| 14,740,000,000 | |
| 13,947,000,000 | |
| 12,618,000,000 | |
| 9,950,000,000 | |
| 9,561,000,000 | |
| 7,829,000,000 | |
| 5,815,000,000 | |
| 5,300,000,000 | |
| 4,966,000,000 | |
| 5,016,000,000 | |
| 4,910,981,000 | |
| 4,499,000,000 | |
| 3,248,000,000 | |
| 2,244,924,948 | |
| 2,150,905,914 | |
| 1,352,061,314 | |
| 1,477,416,631 | |
| 1,393,408,674 | |
| 687,061,107 | |
| 1,678,455,147 | |
| 1,373,403,803 |